Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,394 | 56 | 98.7% |
| Education | $18.93 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $392.98 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $351.45 | 5 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $270.83 | 23 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $98.88 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $87.85 | 1 | $0 (2017) |
| Mylan Specialty L.P. | $41.73 | 2 | $0 (2020) |
| Alkermes, Inc. | $32.00 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.38 | 2 | $0 (2021) |
| OptiNose US, Inc. | $21.06 | 1 | $0 (2020) |
| Corcept Therapeutics | $18.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $149.21 | 4 | Regeneron Healthcare Solutions, Inc. ($98.88) |
| 2023 | $266.02 | 5 | AstraZeneca Pharmaceuticals LP ($234.70) |
| 2022 | $100.77 | 2 | GlaxoSmithKline, LLC. ($85.95) |
| 2021 | $272.91 | 5 | GlaxoSmithKline, LLC. ($153.79) |
| 2020 | $208.88 | 14 | Sunovion Pharmaceuticals Inc. ($146.09) |
| 2019 | $115.20 | 10 | Sunovion Pharmaceuticals Inc. ($76.94) |
| 2018 | $77.83 | 6 | GlaxoSmithKline, LLC. ($25.46) |
| 2017 | $222.15 | 12 | GlaxoSmithKline, LLC. ($94.61) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: VACCINE | ||||||
| 06/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Endocrinology | ||||||
| 06/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $98.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: RESPIRATORY | ||||||
| 10/19/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $77.68 | General |
| Category: Respiratory | ||||||
| 05/18/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $77.41 | General |
| Category: Respiratory | ||||||
| 04/14/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: IMMUNOLOGY | ||||||
| 04/13/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $79.61 | General |
| Category: Respiratory | ||||||
| 02/21/2023 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 10/20/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $85.95 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: GENETIC DISEASE | ||||||
| 12/14/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $104.31 | General |
| Category: Respiratory | ||||||
| 09/21/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: IMMUNOLOGY | ||||||
| 03/25/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $110.36 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2020 | Sunovion Pharmaceuticals Inc. | UTIBRON NEOHALER (Drug), SEEBRI NEOHALER, LONHALA MAGNAIR | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Respiratory | ||||||
| 09/09/2020 | Sunovion Pharmaceuticals Inc. | UTIBRON NEOHALER (Drug), SEEBRI NEOHALER, LONHALA MAGNAIR | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Respiratory | ||||||
| 08/27/2020 | Sunovion Pharmaceuticals Inc. | UTIBRON NEOHALER (Drug), SEEBRI NEOHALER, LONHALA MAGNAIR | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Respiratory | ||||||
| 07/28/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/27/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Respiratory and Allergy | ||||||
| 07/21/2020 | Sunovion Pharmaceuticals Inc. | UTIBRON NEOHALER (Drug), SEEBRI NEOHALER, LONHALA MAGNAIR | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Respiratory | ||||||
| 07/08/2020 | Sunovion Pharmaceuticals Inc. | UTIBRON NEOHALER (Drug), SEEBRI NEOHALER, LONHALA MAGNAIR | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Respiratory | ||||||
| 06/04/2020 | Sunovion Pharmaceuticals Inc. | UTIBRON NEOHALER (Drug), SEEBRI NEOHALER, LONHALA MAGNAIR | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: Respiratory | ||||||
| 05/13/2020 | Sunovion Pharmaceuticals Inc. | UTIBRON NEOHALER (Drug), SEEBRI NEOHALER, LONHALA MAGNAIR | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 39 | 1,848 | $52,506 | $18,998 |
| 2022 | 4 | 96 | 3,856 | $95,649 | $33,154 |
| 2021 | 10 | 194 | 3,850 | $104,170 | $35,939 |
| 2020 | 11 | 257 | 5,357 | $137,450 | $40,371 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 21 | 1,731 | $49,230 | $18,151 | 36.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 18 | 117 | $3,276 | $846.60 | 25.8% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 30 | 2,290 | $65,696 | $26,522 | 40.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 20 | 1,400 | $21,000 | $4,118 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 35 | $5,285 | $1,615 | 30.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 24 | 131 | $3,668 | $898.23 | 24.5% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 28 | 2,142 | $60,918 | $25,991 | 42.7% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 23 | 1,426 | $21,390 | $4,231 | 19.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 36 | $5,436 | $2,032 | 37.4% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 27 | 154 | $4,312 | $941.47 | 21.8% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 23 | 23 | $2,081 | $741.93 | 35.7% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 23 | 23 | $1,817 | $557.56 | 30.7% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 12 | 12 | $4,548 | $428.55 | 9.4% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 11 | 11 | $1,251 | $422.12 | 33.7% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 12 | 12 | $1,548 | $417.78 | 27.0% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 11 | 11 | $869.00 | $176.01 | 20.3% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 35 | 2,210 | $62,844 | $24,233 | 38.6% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 36 | 2,520 | $37,800 | $7,615 | 20.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 42 | $6,342 | $2,012 | 31.7% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 30 | 297 | $8,316 | $1,986 | 23.9% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 26 | 27 | $4,425 | $1,132 | 25.6% |
| 95115 | Injection of incremental dosages of allergen | Office | 2020 | 15 | 170 | $3,910 | $1,087 | 27.8% |
| 94729 | Measurement of lung diffusing capacity | Office | 2020 | 21 | 21 | $2,525 | $803.62 | 31.8% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2020 | 21 | 21 | $7,959 | $767.36 | 9.6% |
| 94375 | Diagnostic testing in a pulmonary function lab | Office | 2020 | 18 | 21 | $1,764 | $358.21 | 20.3% |
About Dr. John Forehand, MD
Dr. John Forehand, MD is a Allergy & Immunology healthcare provider based in Richlands, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902888258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Forehand, MD has received a total of $1,413 in payments from pharmaceutical and medical device companies, with $149.21 received in 2024. These payments were reported across 58 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,394).
As a Medicare-enrolled provider, Forehand has provided services to 586 Medicare beneficiaries, totaling 14,911 services with total Medicare billing of $128,462. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Allergy & Immunology, Pulmonary Disease
- Location Richlands, VA
- Active Since 11/14/2005
- Last Updated 05/28/2020
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1902888258
Products in Payments
- NUCALA (Biological) $229.18
- BREZTRI (Drug) $183.92
- TRELEGY ELLIPTA (Drug) $128.45
- LONHALA MAGNAIR (Drug) $113.32
- UTIBRON NEOHALER (Drug) $109.71
- DUPIXENT (Biological) $98.88
- ENTRESTO (Drug) $87.85
- FASENRA (Biological) $77.68
- TEZSPIRE (Biological) $77.41
- Yupelri (Drug) $41.73
- UTIBRON (Drug) $25.86
- BREO (Drug) $23.81
- Utibron (Drug) $21.94
- Xhance (Drug) $21.06
- Vivitrol 380 mg (Drug) $18.75
- Korlym (Drug) $18.67
- Arikayce (Drug) $16.24
- TAKHZYRO (Biological) $14.82
- OFEV (Drug) $14.81
- TUDORZA PRESSAIR (Drug) $13.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.